Search Results - "Malek, Mojtaba"

A View Beyond HbA1c: Role of Continuous Glucose Monitoring by Chehregosha, Haleh, Khamseh, Mohammad E., Malek, Mojtaba, Hosseinpanah, Farhad, Ismail-Beigi, Faramarz

“…Hemoglobin A1C (HbA1c) is used as an index of average blood glucose measurement over a period of months and is a mainstay of blood glucose monitoring. This…”
Get full text

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review by Maghsoomi, Zohreh, Emami, Zahra, Malboosbaf, Ramin, Malek, Mojtaba, Khamseh, Mohammad E

“…It has been shown that a subgroup of patients with differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages…”
Get full text

Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus by Malek, Mojtaba, Khamseh, Mohammad E., Chehrehgosha, Haleh, Nobarani, Sohrab, Alaei-Shahmiri, Fariba

“…Background The triglyceride-glucose index (TyG), and TyG-driven parameters incorporating TyG and obesity indices have been proposed as reliable indicators of…”
Get full text

Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes by Nobarani, Sohrab, Alaei-Shahmiri, Fariba, Aghili, Rokhsareh, Malek, Mojtaba, Poustchi, Hossein, Lahouti, Maryam, Khamseh, Mohammad E.

“…Aim To explore the association of visceral adipose tissue (VAT) area and non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus…”
Get full text

Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus by Fadaei, Reza, Moradi, Nariman, Baratchian, Mehdi, Aghajani, Hassan, Malek, Mojtaba, Fazaeli, Ali Akbar, Fallah, Soudabeh

“…C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 are two newly discovered adipokines regulating glucose and lipid metabolism. But their role in type 2 diabetes…”
Get full text

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial by Chehrehgosha, Haleh, Sohrabi, Masoud Reza, Ismail-Beigi, Faramarz, Malek, Mojtaba, Reza Babaei, Mohammad, Zamani, Farhad, Ajdarkosh, Hossein, Khoonsari, Mahmood, Fallah, Afshin Eshghi, Khamseh, Mohammad E.

“…Introduction To evaluate the efficacy of empagliflozin compared to pioglitazone in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes…”
Get full text

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial by Attaran, Fereshte, Emami, Sepideh, Sohrabi, Masoudreza, Malek, Mojtaba, Ajdarkosh, Hossein, Khoonsari, Mahmoodreza, Ismail-Beigi, Faramarz, Khamseh, Mohammad E

“…Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a complex metabolic disorder that increases the risk for cardiovascular disease in patients…”
Get full text

Gestational diabetes mellitus: Major risk factors and pregnancy-related outcomes: A cohort study by Kouhkan, Azam, Najafi, Laily, Malek, Mojtaba, Baradaran, Hamid Reza, Hosseini, Roya, Khajavi, Alireza, Khamseh, Mohammad Ebrahim

“…Gestational diabetes mellitus (GDM) is a major pregnancy endocrine problem that has several confirmed risk factors and is associated with adverse…”
Get full text

Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma by Keshavarzi, Azam, Alaei-Shahmiri, Fariba, Fallahi, Babak, Emami, Zahra, Malek, Mojtaba, Khamseh, Mohammad E

“…Radioactive iodine (RAI) therapy is the standard treatment approach after total thyroidectomy in patients with papillary thyroid carcinoma (PTC). We aimed to…”
Get full text

Association of monocyte/high-density lipoprotein cholesterol ratio and the carotid intima-media thickness in diabetic patients by Amouzegar, Atefeh, Mirzaasgari, Zahra, Mehrabi, Ali, Malek, Mojtaba, Alaei-Shahmiri, Fariba, Najafi, Laily, Khajavi, Alireza

“…The goal of this study was to see whether there was a link between the monocyte/high-density lipoprotein cholesterol ratio (MHR) and carotid intima-media…”
Get full text

Elevated mir‐141 in obesity: Insights into the interplay with sirtuin 1 and non‐alcoholic fatty liver disease by Dadkhah Nikroo, Nikta, Jafarinejad, Habib, Yousefi, Zeynab, Abdolvahabi, Zohreh, Malek, Mojtaba, Mortazavi, Pejman, Pazouki, Abdolreza, Mokhber, Somayeh, Nourbakhsh, Mitra

“…Background Changes in gene expression related to obesity are linked to microRNAs, such as miR‐141, which play a crucial role in metabolic homeostasis. Sirtuin…”
Get full text

The Association Between Subclinical Hypothyroidism and Metabolic Syndrome as Defined by the ATP III Criteria by Eftekharzadeh, Anita, Khamseh, Mohammad Ebrahim, Farshchi, Amir, Malek, Mojtaba

“…The association between subclinical hypothyroidism (SCH) and metabolic syndrome (MetS) is a matter of debate. In this study, we aimed to examine the risk of…”
Get more information

Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes by Montazeri, Zeinab, Hashemi-Madani, Nahid, Iraji, Hamed, Sohrabi, Masoudreza, Alaei-Shahmiri, Fariba, Emami, Zahra, Babaei, Mohammad Reza, Malek, Mojtaba, Khamseh, Mohammad E

“…Abstract Introduction Nonalcoholic fatty liver disease (NAFLD) frequently coexists with type 2 diabetes mellitus (T2DM) and synergistically contributes to the…”
Get full text

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study by Hashemi Madani, Nahid, Ismail-Beigi, Faramarz, Poustchi, Hossein, Nalini, Mahdi, Sepanlou, Sadaf G, Malek, Mojtaba, Abbasi, Mohammad Amin, Khajavi, Alireza, Khamseh, Mohammad E, Malekzadeh, Reza

“…Whether pre-diabetes in the absence of hypertension (HTN) or dyslipidemia (DLP) is a risk factor for occurrence of major adverse cardiovascular events (MACE)…”
Get full text

The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial by Safari, Mostafa, Asadi, Akbar, Aryaeian, Naheed, Huseini, Hasan Fallah, Shidfar, Farzad, Jazayeri, Shima, Malek, Mojtaba, Hosseini, Agha Fateme, Hamidi, Zahra

“…Depression is more common in diabetic patients, with a 1.5-fold increased risk of death.Melissa officinalis (M. officinalis) have anti-diabetic and…”
Get full text

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM) by Soltanieh, Samira, Salavatizadeh, Marieh, Poustchi, Hossein, Yari, Zahra, Mansour, Asieh, Khamseh, Mohammad E., Malek, Mojtaba, Alaei-Shahmiri, Fariba, Hekmatdoost, Azita

“…High prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus results in deleterious complications and morbidities…”
Get full text

Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran by Khamseh, Mohammad E, Baradaran, Hamid R, Javanbakht, Anna, Mirghorbani, Maryam, Yadollahi, Zahra, Malek, Mojtaba

“…The quality of life in patients with various chronic disorders, including diabetes has been directly affected by depression. Depression makes patients less…”
Get full text

Type 2 Diabetes: Model of Factors Associated with Glycemic Control by Aghili, Rokhsareh, MD, PhD, Polonsky, William H., PhD, CDE, Valojerdi, Ameneh Ebrahim, BSc, Malek, Mojtaba, MD, Keshtkar, Abbas Ali, MD, PhD, Esteghamati, Alireza, MD, Heyman, Mark, PhD, Khamseh, Mohammad Ebrahim, MD

“…Abstract Objectives The purpose of this study was to evaluate the related factors and their intercorrelated impacts on glycemic control in people with type 2…”
Get full text

Effect of Royal Jelly Intake on Serum Glucose, Apolipoprotein A-I (ApoA-I), Apolipoprotein B (ApoB) and ApoB/ApoA-I Ratios in Patients with Type 2 Diabetes: A Randomized, Double-Blind Clinical Trial Study by Khoshpey, Basemeh, MSc, Djazayeri, Shima, MD, PhD, Amiri, Fatemehsadat, MSc, PhD, Malek, Mojtaba, MD, Hosseini, Agha Fateme, MSc, Hosseini, Sharieh, MSc, PhD, Shidfar, Shahrzad, MD, Shidfar, Farzad, MSc, PhD

“…Abstract Objectives Type 2 diabetes is the most common metabolic disorder worldwide. Evidence supports a role for royal jelly (RJ) in reduction of serum…”
Get full text

Does Supplementation with Royal Jelly Improve Oxidative Stress and Insulin Resistance in Type 2 Diabetic Patients? by Shidfar, Farzad, Jazayeri, Shima, Mousavi, Seyedeh Neda, Malek, Mojtaba, Hosseini, Agha Fateme, Khoshpey, Basmeh

“…Animal studies have shown antioxidant effects of Royal Jelly (RJ) and its effect on insulin resistance as the most common complication of Type 2 diabetes. This…”
Get full text